baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Financial Statements
- Click here to download Baxter International Inc.'s Income Statement
- Click here to download Baxter International Inc.'s Balance Sheet
- Click here to download Baxter International Inc.'s Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Jose Almeida
Key Statistics
- Stock Price: $42.74
- Dividend Yield: 2.7%
- Market Capitalization: $21,704,544,657
- Shares Outstanding: 507,827,437
- Number of Employees: 32,403
- Trailing 12-Month EPS: $5.25
- Trailing 12-Month DPS: $1.15
- Payout Ratio: 21.9%
Important Dates
- Next Earnings Date: 2024-05-02
- Next Ex-Dividend Date: 2024-02-29
Price Trends
- Current Stock Price: $42.74
- 52-week high: $49.12
- 52-week low: $30.55
- 200-day moving average: $37.63
- 50-day moving average: $41.82
Performance
- 1-Month Price Return: 3.6%
- 3-Month Price Return: 11.3%
- 6-Month Price Return: 15.0%
- 1-Year Price Return: 9.2%
- 2-Year Price Return: -43.4%
- 5-Year Price Return: -42.7%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast